0001179110-20-009902.txt : 20200921
0001179110-20-009902.hdr.sgml : 20200921
20200921175501
ACCESSION NUMBER: 0001179110-20-009902
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200921
FILED AS OF DATE: 20200921
DATE AS OF CHANGE: 20200921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friend Cynthia M
CENTRAL INDEX KEY: 0001675108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 201187360
MAIL ADDRESS:
STREET 1: C/O BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
4
1
edgar.xml
FORM 4 -
X0306
4
2020-09-21
0
0001109354
BRUKER CORP
BRKR
0001675108
Friend Cynthia M
BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
1
0
0
0
Common Stock
2020-09-21
4
M
0
800
26.17
A
12657
D
Common Stock
2020-09-21
4
S
0
800
37.5813
D
11857
D
Stock Option (Right to Buy)
26.17
2020-09-21
4
M
0
800
0
D
2026-05-20
Common Stock
800
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.79, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested in three approximately equal annual installments on May 20, 2017, 2018 and 2019.
/s/ Michael Rich, Attorney-in-Fact
2020-09-21